Bevacizumab for glioblastoma
Yoshitaka Narita Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan Abstract: Individuals with glioblastoma are often characterized by older age, advanced neurologic manifestations at the primary stage, and unresectable tumors, and these factors are associ...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-12-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | https://www.dovepress.com/bevacizumab-for-glioblastoma-peer-reviewed-article-TCRM |